Display Settings:


Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Diabetologia. 2002 Oct;45(10):1468-74. Epub 2002 Sep 5.

Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination.

Author information

  • The Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel. Irun.Cohen@weizmann.ac.il


The autoimmune process that produces Type I (insulin-dependent) diabetes mellitus seems to respond favourably to therapeutic vaccination with a peptide of the 60 kDa heat shock protein. This article is a personal review of the observations and the thinking that gave rise to the idea of therapeutic peptide vaccination. The rationale for vaccination therapy is compared to other approaches aimed at specific immunological treatment for autoimmune disease.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk